International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 1 | Views: 245

Review Papers | Health and Medical Sciences | Namibia | Volume 10 Issue 6, June 2021 | Popularity: 5 / 10


     

Delaying Bacillus Calmette-Guerin (BCG) Vaccine in HIV-Exposed Infants: A Systematic Review and Meta-Analysis

Jonathan Lukusa Tshimwanga, Jacques Lukenze Tamuzi


Abstract: Background: Infants who have been exposed to the human immunodeficiency virus (HIV) are at a higher risk of contracting Mycobacterium tuberculosis, have a higher chance of developing tuberculosis (TB), and are more likely to experience bacillus Calmette-Guerin (BCG)-related side effects. The only antituberculosis (TB) vaccine now available is Bacillus Calmette Gu?rin (BCG). We assessed when BCG may be given to an HIV-exposed uninfected (HEU) infant without exposing the child to HIV or tuberculosis. Objective: To establish the best time for administering BCG vaccination to HIV-exposed infants and to evaluate the impact of administering BCG vaccine at birth vs delaying BCG vaccine at delivery. Methods: We searched in studies related to the subject in different databases: Web of Science, LILACS, CENTRAL (Cochrane Central Register of Controlled Trials), PubMed and CINAHL, Scopus, as well as conference abstracts from the HIV/AIDS website, then we conducted a systematic review and Meta-analysis. Results: CD4+ T cells activation after 14 weeks comparing BCG delayed to BCG given at birth in HIV-exposed infants, the random-effects meta-analysis of CD4+ T cells activation (14 weeks) yielded a pooled MD estimate of -3.58 (95% CI -6.73 to -0.43, P=0.03) with I2= 97%. Conclusion: In HIV-exposed uninfected (HEU) infant, BCG vaccination causes immunological alterations, and the intensification in the percentage of activated CCR5+CD4+ HIV target cells. Therefore, delaying BCG vaccine would be advantageous to HEU rather than giving it shortly after the delivery, but more evidenceis still need to while exploring this new paradigm.


Keywords: Bacillus Calmette-Guerin, BCG, Vaccine, HIV, Infants


Edition: Volume 10 Issue 6, June 2021


Pages: 1729 - 1736



Make Sure to Disable the Pop-Up Blocker of Web Browser




Text copied to Clipboard!
Jonathan Lukusa Tshimwanga, Jacques Lukenze Tamuzi, "Delaying Bacillus Calmette-Guerin (BCG) Vaccine in HIV-Exposed Infants: A Systematic Review and Meta-Analysis", International Journal of Science and Research (IJSR), Volume 10 Issue 6, June 2021, pp. 1729-1736, https://www.ijsr.net/getabstract.php?paperid=SR21625211803, DOI: https://www.doi.org/10.21275/SR21625211803



Similar Articles

Downloads: 1 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Review Papers, Health and Medical Sciences, India, Volume 12 Issue 11, November 2023

Pages: 1896 - 1898

A Clinical Review on Samangadi Lehya as an Immunity Booster

Priyanka Tripathi, Dr. Laxmi

Share this Article

Downloads: 1 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Informative Article, Health and Medical Sciences, India, Volume 11 Issue 6, June 2022

Pages: 1988 - 1990

Vaccination Mandates - Impacts & Ethics

Swapna Nadakuditi

Share this Article

Downloads: 3 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Comparative Studies, Health and Medical Sciences, Somalia, Volume 13 Issue 2, February 2024

Pages: 225 - 230

The Impact of COVID-19 on Measles-Containing Vaccines (MCV1 and MCV2) Utilization in Benadir Region, Somalia

Abdirahman Omar Abdi

Share this Article

Downloads: 6 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Research Paper, Health and Medical Sciences, Somalia, Volume 11 Issue 1, January 2022

Pages: 409 - 417

Level of Infection Control Measures in Hospitals Case Study: Rubaga and Entebbe Grade B Hospitals

Mohamed Daud Mohamud

Share this Article



Top